CD274 and sarcoma: Groisberg et al.14 analyzed the medical records of patients with advanced sarcomas referred to MD Anderson Phase I clinic, who received immunotherapeutic [checkpoint inhibitors (anti-PD1, anti-PD-L1, anti CTLA4, etc.)vaccines and cytokine-based therapies].